GIS W4 Colon Pharmacology Flashcards

1
Q

What critical metabolites produced during fermentation of fiber promote intestinal gluconeogenesis?

A

Proprionate and butyrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What critical metabolite produced during fermentation of fiber induces Treg cells to dampen inflammation?

A

Acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In the small intestine, what cells on the villi absorb fluid?
What is the process driven by?

A

Cells at the tips of villi, Na+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the small intestine, what cells on the villi secrete fluid? What is the process driven by?

A

Cells in the crypts, CL-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Na+, K+ and Cl- are brought across the basolateral membrane via the _______ symporter

A

NKCC1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cations are transported back across the basolateral membrane via ______________________.

A

Na+/K+ ATPase and K+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cl- is moved across the apical membrane by _____.

d) Na+ and H2O follow via the ______________.

A

CFTR

paracellular route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

13) Short Bowel Syndrome Treatment

b) Glucagon-like peptide 2 (GLP-2) analogue

A

TEDUGLUTIDE

binds to enteric neurons and endocrine cells  release of trophic hormones that increase mucosal epithelial growth  enhance fluid and nutrient absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

a) In the absence of nutrient absorption, Na+ enters colonocytes via a ________________

A

sodium channel (ENaC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

________ is a peptide hormone (released by goblet cells) that activates guanylyl cyclase C (GC-C) which increases cGMP

c) Increases in cGMP or cAMP increase flow through CFTR

A

GUANYLIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This Diarrhea causes excess secretion of chloride and/or inhibition of NaCl transport across apical membrane
ii) Causes: infection, inflammation

A

a) Secretory diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

This diarrhea changes in luminal contents result in water being pulled from bloodstream
ii) Causes: Incomplete absorption

A

b) Osmotic diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

This drug affects chloride secretion

a) Activator of CIC-2

A

LUBIPROSTONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LINACLOTIDE MOA

A

This drug is an activator of GC-C

i) Activates guanylyl cyclase C  increase cGMP  activation of CFTR  increase Cl- secretion  retention of H2O in lumen  looser stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CROFELEMER MOA

A

This drug is an inhibitor of CFTR

i) Voltage-independent inhibition of CFTR (and one other chloride channel)  decrease Cl- secretion  increase absorption of H2O from lumen  firmer stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

OCTREOTIDE MOA

A

This drug is a Somatostatin analogue

ii) Multiple effects on GI tract:
(1) 1) decreases 5HT-stimulated, cGMP-dependent Cl- secretion
(2) 2) decreased NT/hormone release (esp. 5-HT) 3) low doses increase motility, high doses decrease motility

17
Q

BISMUTH SUBSALICYLATE MOA

A

Cox inhibitor

i) Salicylate  decreased prostaglandin synthesis  decreased cAMP  decreased Cl- secretion  increased absorption of H2O from lumen  firmer stool

18
Q

LUBIPROSTONE MOA

A

i) Increased Cl- secretion –> retention of H2O in lumen –> looser stool

19
Q

LACTULOSE, MAGNESIUM HYDROXIDE, SODIUM PHOSPHATE, POLYETHYLENE GLYCOL

MOA

A

b) Osmotic cathartics

i) Not absorbed  increased retention of H2O in lumen due to osmosis  looser stool

20
Q

specifically decreases plasma ammonia concentrations –> used to treat portal systemic encephalopathy

A

ii) LACTULOSE

21
Q

i) CHOLESTYRAMINE, COLESTIPOL

MOA

A

Bile acid binding resins

(1) decrease reabsorption of bile salts (Crohn’s disease, resection of terminal ileum)  secretory diarrhea

22
Q

These SSRIs are effective treatments for constipation-predominant IBS

A

FLUOXETINE, PAROXETINE, SERTALINE

ii) decrease reuptake 5-HT into ECL cells  increased 5-HT in the synapse
 increase primary afferent activity  increase peristalsis

23
Q

Bulk laxatives MOA

A

increase the stimulation of mechanoreceptors

ii) Attract water and increase stool mass

24
Q

DIETARY FIBER, METHYLCELLULOSE, PSYLLIUM are classified as…

A

BULK LAXATIVES:

25
Q

f) Contact cathartics MOA

A

are thought to stimulate the peristaltic reflex

26
Q

ANTHRAQUINONE DERIVATIVES, BISACODYL, and CASTOR OIL are classified as…

A

CONTACT (IRRITANT) CATHARTICS

27
Q

___________is a prodrug; must be converted to ricinoleic acid
(1) Acts on both the small and large intestine  shorter latency and more significant side effects

A

CASTOR OIL

28
Q

This 5-HT3 antagonist decreases gastric motility

A

ALOSETRON

29
Q

TEGASEROD and CISAPRIDE MOA

A

5-HT4 agonists increase gastric motility

Activation of presynaptic receptors  increases NT release from myenteric neurons  increases peristalsis

30
Q

DOMPERIDONE and METOCLOPRAMIDE MOA

A

D2 receptor antagonists

Inhibition of dopamine inhibition  increase actions of ACh in gut (i.e., they are cholinomimetics)  increase motility in entire gut (i.e., they are prokinetic)

31
Q

DIPHENOXYLATE and LOPERAMIDE MOA

A

Opiates: decrease motility and secretion

32
Q

ALVIMOPAN and METHYLNALOXONE MOA

A

μ receptor antagonists

Selective antagonists that don’t cross the BBB  increase gastric motility

33
Q

Drugs directly affecting cholinergic function are NOT used to treat diarrhea or constipation, but what are TWO EXCEPTIONS

A

i) TRICYCLIC ANTIDEPRESSANTS (AMITRIPTYLINE, DESIPRAMINE)

and

ii) ATROPINE

34
Q

Prokinetics

A

(1) D2 receptor antagonists: DOMPERIDONE (restricted use), METOCLOPRAMIDE
(2) Macrolides: ERYTHROMYCIN
(3) 5HT4 Agonists: CISAPRIDE (
restricted use)

35
Q

Antidiarrheals

A

ii) Opiates: LOPERAMIDE, DIPHENOXYLATE+ATROPINE
(1) Multiple uses including traveler’s diarrhea
iii) BABRs: CHOLESTYRAMINE, COLESTIPOL
(1) Malabsorption of bile salts (Crohn’s disease, resection of terminal ileum
iv) OCTREOTIDE: severe diarrhea due to dumping syndrome, short bowel syndrome, vagotomy, AIDS
v) BISMUTH SUBSALYCILATE: traveller’s diarrhea
vi) CREFELEMER: diarrhea due to AIDS